2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with Hypoxia-Ischemia, Brain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YC; Chou, DS; Hsiao, G; Lee, JJ; Lin, JH; Lin, KH; Shen, MY; Sheu, JR | 1 |
1 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and Hypoxia-Ischemia, Brain
Article | Year |
---|---|
Neuroprotective effects of PMC, a potent alpha-tocopherol derivative, in brain ischemia-reperfusion: reduced neutrophil activation and anti-oxidant actions.
Topics: alpha-Tocopherol; Animals; Antioxidants; Caspase 3; Chromans; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Ischemia, Brain; Male; Molecular Structure; Neuroprotective Agents; Neutrophil Activation; Neutrophils; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine | 2007 |